{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:57:14Z","timestamp":1791568634585,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"AP-HP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jcv.2025.105776","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:54:19Z","timestamp":1741280059000},"page":"105776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Evaluation of the analytical performances of the Alinity-i HSV-1 IgG and HSV-2 IgG chemiluminescent immunoassays"],"prefix":"10.1016","volume":"177","author":[{"given":"Joachim","family":"Bourdin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Salmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadhira","family":"Fidouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Fou\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"LeGoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-4381","authenticated-orcid":false,"given":"Sarah","family":"Maylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jcv.2025.105776_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.jcv.2025.105776_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/sti.2003.006783","article-title":"HSV type specific serology in sexual health clinics: use, benefits, and who gets tested","volume":"80","author":"Song","year":"2004","journal-title":"Sex. Transm. Infect."},{"issue":"11","key":"10.1016\/j.jcv.2025.105776_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.olq.0000143089.77493.c2","article-title":"Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults","volume":"31","author":"Zimet","year":"2004","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jcv.2025.105776_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2017.12.006","article-title":"Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens","volume":"99\u2013100","author":"Sam","year":"2018","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"issue":"11","key":"10.1016\/j.jcv.2025.105776_bib5","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1128\/JCM.01685-12","article-title":"Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test","volume":"50","author":"Van Der Pol","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.jcv.2025.105776_bib6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jama.2022.20356","article-title":"Serologic screening for genital herpes: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"329","author":"Asher","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jcv.2025.105776_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jcla.21725","article-title":"Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease","volume":"29","author":"Al-Shobaili","year":"2015","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.jcv.2025.105776_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22203","article-title":"Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG","volume":"32","author":"de Ory","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jcv.2025.105776_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2014.01.001","article-title":"Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays","volume":"199","author":"Liermann","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2025.105776_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12879-015-1130-6","article-title":"Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment","volume":"15","author":"Patel","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.jcv.2025.105776_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1128\/CVI.05003-11","article-title":"Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings","volume":"18","author":"LeGoff","year":"2011","journal-title":"Clin. Vaccin. Immunol."},{"issue":"6","key":"10.1016\/j.jcv.2025.105776_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00263-24","article-title":"Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing","volume":"62","author":"Crawford","year":"2024","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl. 2","key":"10.1016\/j.jcv.2025.105776_bib13","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/cid\/ciab1056","article-title":"Diagnosis and management of genital herpes: key questions and review of the evidence for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines","volume":"74","author":"Johnston","year":"2022","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"issue":"2","key":"10.1016\/j.jcv.2025.105776_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/JCM.40.2.407-413.2002","article-title":"Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2","volume":"40","author":"Eing","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.jcv.2025.105776_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00007435-200102000-00007","article-title":"Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics","volume":"28","author":"Whittington","year":"2001","journal-title":"Sex. Transm. Dis."},{"issue":"10","key":"10.1016\/j.jcv.2025.105776_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.OLQ.0000092387.58746.C7","article-title":"Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students","volume":"30","author":"Roberts","year":"2003","journal-title":"Sex. Transm. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2025.105776_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/OLQ.0000000000001603","article-title":"Characterization of serum samples with discordant results in 2 herpes simplex virus type 2 IgG assays","volume":"49","author":"Prince","year":"2022","journal-title":"Sex. Transm. Dis."},{"issue":"12","key":"10.1016\/j.jcv.2025.105776_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/OLQ.0000000000000689","article-title":"Performance of commercial enzyme-linked immunoassays for diagnosis of herpes simplex virus-1 and herpes simplex virus-2 infection in a clinical setting","volume":"44","author":"Agyemang","year":"2017","journal-title":"Sex. Transm. Dis."},{"issue":"11","key":"10.1016\/j.jcv.2025.105776_bib19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7326\/0003-4819-121-11-199412010-00004","article-title":"Recurrence rates in genital herpes after symptomatic first-episode infection","volume":"121","author":"Benedetti","year":"1994","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.jcv.2025.105776_bib20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00007435-200207000-00011","article-title":"Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory","volume":"29","author":"Turner","year":"2002","journal-title":"Sex. Transm. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2025.105776_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."},{"issue":"4","key":"10.1016\/j.jcv.2025.105776_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/jcm.26.4.662-667.1988","article-title":"Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera","volume":"26","author":"Ashley","year":"1988","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.jcv.2025.105776_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/infdis\/140.4.487","article-title":"Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation","volume":"140","author":"Pass","year":"1979","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.jcv.2025.105776_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4735","article-title":"Clinical variability of recurrent oral HSV-1 infection with a high level of serum IgG antibody: three case reports","volume":"9","author":"Zakiawati","year":"2021","journal-title":"Clin. Case Rep."},{"issue":"10","key":"10.1016\/j.jcv.2025.105776_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/OGX.0b013e31823983ec","article-title":"Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections","volume":"66","author":"Westhoff","year":"2011","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.jcv.2025.105776_bib26","article-title":"European guidelines for the management of genital herpes","author":"Patel","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9","key":"10.1016\/j.jcv.2025.105776_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13526","article-title":"Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Lee","year":"2019","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jcv.2025.105776_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13548","article-title":"Screening of donor and candidate prior to solid organ transplantation\u2014guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Malinis","year":"2019","journal-title":"Clin. Transplant."},{"issue":"7","key":"10.1016\/j.jcv.2025.105776_bib29","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/v15071595","article-title":"Current perspectives on the management of herpesvirus infections in solid organ transplant recipients","volume":"15","author":"Malahe","year":"2023","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.jcv.2025.105776_bib30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jhep.2013.12.021","article-title":"Management of infections pre- and post-liver transplantation: report of an AISF consensus conference","volume":"60","author":"Fagiuoli","year":"2014","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.jcv.2025.105776_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.jcv.2025.105776_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jcv.2025.105776_bib33","first-page":"359","article-title":"Performance of two commercial enzyme-linked immunosorbent assay kits using recombinant glycoprotein G2 antigen for detection of herpes simplex virus type 2 specific antibodies","volume":"12","author":"Reddy","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.jcv.2025.105776_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ. Psychol. Meas."},{"issue":"3","key":"10.1016\/j.jcv.2025.105776_bib35","first-page":"275","article-title":"Evaluation of virological microparticle enzyme immunoassay according to the ISO 15189: real-life experience in a university hospital","volume":"62","author":"Lafontaine","year":"2016","journal-title":"Clin. Lab."},{"issue":"17","key":"10.1016\/j.jcv.2025.105776_bib36","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.2022.19061","article-title":"Viral shedding 1 year following first-episode genital HSV-1 infection","volume":"328","author":"Johnston","year":"2022","journal-title":"JAMA"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T07:02:58Z","timestamp":1744441378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653225000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"alternative-id":["S1386653225000174"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105776","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the analytical performances of the Alinity-i HSV-1 IgG and HSV-2 IgG chemiluminescent immunoassays","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105776"}}